Your browser is not supported. Please upgrade to a modern browser in order to use all the features of the UKHC web application: Firefox | Chrome | Microsoft Edge
Skip to main content
close menu
close menu

Search UK HealthCare

Menu
Open search dialog Magnifying Glass My UK HealthCare

Markey Cancer Center

COVID-19

× Close UK HealthCare Coronavirus Information Arrow Pointing Right

Lung Cancer

Dr. Mullet and lung cancer patient, Vickie Duff
After being treated for late-stage lung cancer by Markey cardiothoracic surgeon Timothy Mullett, MD, FACS, Vickie Duff has now been cancer free for seven years. Read more in Markey's 2016 Annual Report.

high-performing-lungIn the UK Markey Cancer Center’s Multidisciplinary Thoracic Clinic, lung cancer patients are provided customized care to fit their oncology needs. Our program offers the latest in thoracic surgery, radiation therapy, chemotherapy treatments, and more.

Our team approach

The Multidisciplinary Thoracic Oncology Program includes multiple oncology specialists with a broad range of expertise in all aspects of lung cancer care and treatment. Our team provides expertise and offers patients personalized care and treatment plans suited for their needs.

Markey has provided state-of-the-art cancer care for more than 20 years, and we are proud to be the only cancer center in Kentucky designated by the National Cancer Institute. In August 2017, Markey was designated as one of the Top 50 Cancer Centers in the nation by U.S. News & World Report. In 2020, Markey rose to the No. 29 ranked cancer center in the nation.

Conditions commonly treated include small cell lung cancer and non-small cell lung cancer, mesothelioma, thymic tumors, and other thoracic cancers including esophageal cancer and tumors of the mediastinum. Thoracic surgery, interventional pulmonary medicine, radiation, chemotherapy and precision medicine treatments are state-of-the-art, supplemented by national research studies as well as treatments with promising new drug regimens.

Survival rates

According to the American Cancer Society (ACS), about 14 percent of all new cancers diagnosed are lung cancers. In 2016, Markey had a 17 percent five-year survival rate among lung cancer patients.

Despite the serious prognosis of lung cancer, more people are living with lung cancer now than ever. According to ACS, more than 430,000 people alive today have been diagnosed with lung cancer at some point.

The earlier lung cancer is discovered, the sooner your treatment can begin. See our Lung Cancer Screening page for more information on our Lung Cancer Screening Program.

Clinical trials

Clinical Trials help keep our cancer care on the leading edge by allowing researchers to apply cancer knowledge as it develops to give you the best chance of survival.

At Markey, our specialists place a high value on all areas of lung cancer treatment, from patient care designed for the unique patient to developing treatments of the future.

Visit Markey’s Clinical Trials webpage for more information on how to participate, as well as the NCI Clinical Trials webpages for additional resources.

  • Your visit

    • For your first visit, you will be directed to the multidisciplinary clinic on the first floor of the Whitney-Hendrickson Building. Directions to the Whitney-Hendrickson Building.
    • After registering at the front desk, a receptionist will help guide you through your appointment.
    • Free parking is available to patients in the Whitney-Hendrickson parking lot.
    • Please remember to bring your patient packet with the completed forms. These items will help your doctor learn more about your case and determine the best plan for your care.
    • Review the patient handbook to learn about your stay and everything Markey offers for patients and families.

    UK HealthCare accepts many forms of insurance.